186 related articles for article (PubMed ID: 22025191)
1. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
2. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
[TBL] [Abstract][Full Text] [Related]
4. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
Yayla ME; İlgen U; Düzgün N
Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
[TBL] [Abstract][Full Text] [Related]
7. Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.
Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Sato S; Kikuchi K; Tamaki K
Clin Exp Immunol; 1999 Aug; 117(2):383-7. PubMed ID: 10444274
[TBL] [Abstract][Full Text] [Related]
8. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
9. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.
Chang M; Wang RJ; Yangco DT; Sharp GC; Komatireddy GR; Hoffman RW
Clin Immunol Immunopathol; 1998 Oct; 89(1):71-8. PubMed ID: 9756726
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.
Satoh M; Ajmani AK; Ogasawara T; Langdon JJ; Hirakata M; Wang J; Reeves WH
J Clin Invest; 1994 Nov; 94(5):1981-9. PubMed ID: 7962544
[TBL] [Abstract][Full Text] [Related]
11. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
12. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
[TBL] [Abstract][Full Text] [Related]
13. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
14. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Guialis A; Tzioufas G; Moutsopoulos HM
Br J Rheumatol; 1996 Jun; 35(6):534-41. PubMed ID: 8670573
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
[TBL] [Abstract][Full Text] [Related]
16. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
[TBL] [Abstract][Full Text] [Related]
19. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
